Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

No Crisis for These 6 European Stocks


These global powerhouses with strong business franchises are more resistant to a slowdown in Europe than multinational companies based in the US or Asia.

Despite their global strength, these companies have had weak stocks in recent months as Europe's woes make headlines almost daily. In addition to powerful brands and international reach, a number of them have very attractive dividend yields.

Sure, Europe has a lot of problems, and they are not likely to be fixed anytime soon. But the problems are well known.

Baron Rothschild is reputed to have said, "The time to buy is when there is blood in the streets." If he was right, this might be a good time to look at European stocks.

1. Koninklijke Philips Electronics (PHG)
The GE of Europe (but without GE's big financial services business). And like GE, Philips' stock rallied strongly into the end of the last decade but has stagnated ever since.

Management, however, hasn't sat still -- the company has effected significant corporate changes that have streamlined operations. While Europe is its largest market, fully two-thirds of revenues are derived from outside its home turf.

The latest quarter, though soft, showed some stability in operating momentum, and the stock's valuation and dividend yield are quite attractive.

2. LM Ericsson Telephone (ERIC)
A global maker of telecommunications equipment. Results in recent years have been hurt by Ericsson's joint venture with Sony in the ultra-competitive cellphone handset market, but the company is in the process of getting out of that business.

Other lines of business are doing well, with particularly good growth in South America and Asia. The company should also see opportunities in its service operations, a fragmented market in which Ericsson is considered to be a market leader.

3. Novartis (NVS)
Born in 1996 as a result of the merger of two Swiss drugmakers, Ciba-Geigy and Sandoz, Novartis has acquisitions that have continued to be a key element in the firm's growth and diversification efforts.

Though prescription drugs account for some 60% of sales, Novartis has a strong generic division as well as a presence in vaccines, diagnostics, and consumer health.

A strong pipeline of new products, attractive growth metrics in emerging markets, and solid operating cash flows bode well for patient investors.

4. Smith & Nephew (SNN)
This company has been involved in medical technologies since 1856. Over the last decade or so, the company has focused on advanced wound management, endoscopy, and orthopedics.

Recent operating results have been decent, but headwinds in the form of European austerity and shifting US health care regulations have kept investors on edge.

A new CEO is expected to use acquisitions and an emphasis on emerging markets to spur long-term gains. The company's size, worldwide scope, and solid financials bode well for continued success.

5. STMicroelectronics (STM)
A leader in semiconductors that help with power consumption and battery life, it is also a supplier of gyroscope chips for Apple's (AAPL) iPhone.

Management has shuffled the company's assets in recent years, including exiting the memory-chip business and entering a wireless-chip joint venture with a division of Ericsson.

Although the near-term outlook is cloudy, the stock is attractively valued, and the dividend pays you well in case you have to wait for a tech rebound.

6. Telefonica (TEF)
This has long been thought of as a Spanish company, but it actually has one of the more international profiles in the telecom sector. Roughly two-thirds of revenues come from outside its homeland.

Latin America is a substantial market, as are other European countries such as the UK, Ireland, Germany, Czech Republic, and Slovakia. The company recently entered the Chinese market via an equity stake in China Unicom (CHU).

Sales in 2010 rebounded strongly, and operations returned to profitability. The generous dividend of 8.2% appears secure.

Editor's Note: This article was written by George Putnam of The Turnaround Letter.

Below, find some more great investing and trading content from MoneyShow:

A Defensive Fund for Chilly Times
By Kathryn Young

3 Auto-Parts Stocks Warming Up
By Kate Stalter

What To Look For in Tech Stocks
By Patrick McKeough

Safe Way to Fix the MF Global Fallout
By Andy Waldock

Twitter: @TopProsTopPicks

No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos